Concert Presents During Late-Breaking News Session at EADV 2020 Virtual Congress
Concert Pharmaceuticals presented during the late-breaking news session at the European Academy of Dermatology and Venereology (EADV) Virtual Congress on Thursday, October 29, 2020. The presentation by Jim Cassella, Concert’s Chief Development Officer, focused on data from a long-term, open label extension study of CTP-543, an investigational treatment being developed for alopecia areata.
About EADV
EADV is a non-profit association dedicated to advancing patient care, education and research in the field of dermatology and venereology by providing a unique platform to bring people together and share ideas. Founded in 1987, EADV is the leading community to further the knowledge of health professionals and advocates in the field of dermatology and venereology. EADV organizes one main congress annually.
